Interleukin-25 and interleukin-33 as mediators of eosinophilic inflammation in chronic rhinosinusitis

American Journal of Rhinology and Allergy

Volumn 29, Issue 3, 2015, Pages 175-181

  Lam, Matthew ^a,b   Hull, Laura ^a,b   Imrie, Andrew ^a   Snidvongs, Kornkiat ^c,d   Chin, David ^e   Pratt, Ellie ^f   Kalish, Larry ^g   Sacks, Raymond ^c,f   Earls, Peter ^e   Sewell, William ^a,b   Harvey, Richard J ^a,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c MACQUARIE UNIVERSITY   (Australia)

^d CHULALONGKORN UNIVERSITY   (Thailand)

^e ST VINCENT S HOSPITAL   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

^g ANZAC Research Institute   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 25; INTERLEUKIN 33; MESSENGER RNA; THYMIC STROMAL LYMPHOPOIETIN; AUTACOID; CYTOKINE; IL25 PROTEIN, HUMAN; IL33 PROTEIN, HUMAN; INTERLEUKIN 17;

ADULT; ARTICLE; CHRONIC RHINOSINUSITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EOSINOPHIL; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MIDDLE AGED; NOSE POLYP; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; AGED; CHRONIC DISEASE; EOSINOPHILIA; IMMUNOLOGY; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RHINITIS; SINUSITIS;

ADULT; AGED; CHRONIC DISEASE; CYTOKINES; EOSINOPHILIA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; INTERLEUKIN-17; INTERLEUKIN-33; MALE; MIDDLE AGED; RHINITIS; SINUSITIS;

EID: 84929735016     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2015.29.4176     Document Type: Article

References (33)

1. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 114:155-212, 2004.
2. Van Crombruggen K, Zhang N, Gevaert P, et al. Pathogenesis of chronic rhinosinusitis: Inflammation. The Journal of allergy and clinical immunology 128:728-732, 2011.
3. Snidvongs K, Lam M, Sacks R, et al. Structured histopathology profiling of chronic rhinosinusitis in routine practice. Int Forum Allergy Rhinol 2:376-385, 2012.
4. Payne SC, Borish L, and Steinke JW. Genetics and phenotyping in chronic sinusitis. J Allergy Clin Immunol 128:710-20, 2011.
5. Zhu J, and Paul WE. CD4 T cells: fates, functions, and faults. Blood 112:1557, 2008.
6. Paul WE, Zhu J. How are TH2-type immune responses initiated and amplified? Nat Rev Immunol 10:225-235, 2010.
7. Neill DR, Wong SH, Bellosi A, et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464:1367- 1370, 2010.
8. Saenz SA, Siracusa MC, Perrigoue JG, et al. IL25 elicits a multipotent progenitor cell population that promotes TH2 cytokine responses. Nature 464:1362-1366, 2010.
9. Siracusa MC, Saenz SA, Hill DA, et al. TSLP promotes interleukin- 3-independent basophil haematopoiesis and type 2 inflammation. Nature 477:229-233, 2011.
10. Saenz SA, Taylor BC, Artis D. Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites. Immunol Rev 226:172-190, 2008.
11. Wisniewski JA, and Borish L. Novel cytokines and cytokine-producing T cells in allergic disorders. Allergy Asthma Proc 32:83-94, 2011.
12. Hurst SD, Muchamuel T, Gorman DM, et al. New IL-17 family members promote Th1 or Th2 responses in the lung: In vivo function of the novel cytokine IL-25. J Immunol 169:443-453, 2002.
13. Kim MR, Manoukian R, Yeh R, et al. Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production. Blood 100:2330-2340, 2002.
14. Fallon PG, Ballantyne SJ, Mangan NE, et al. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J Exp Med 203: 1105-1116, 2006.
15. Humphreys NE, Xu D, Hepworth MR, et al. IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J Immunol 180:2443-2449, 2008.
16. Smithgall MD, Comeau MR, Park Yoon BR, et al. IL-33 amplifies both Th1-and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int Immunol 20:1019-1030, 2008.
17. Oboki K, Ohno T, Kajiwara N, et al. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci USA 107:18581-18586, 2010.
18. Liu YJ, Soumelis V, Watanabe N, et al. TSLP: An epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Ann Rev Immunol 25:193-219, 2007.
19. Zhou B, Comeau MR, Thibaut De Smedt H, et al. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol 6:1047-1053, 2005.
20. Yoo J, Omori M, Gyarmati D, et al. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J Exp Med 202:541-549, 2005.
21. Fokkens W, Lund V, and Mullol J. European position paper on rhinosinusitis and nasal polyps rhinology 2007. Rhinol Suppl. 20:1- 136, 2007.
22. Kern RC, Conley DB, Walsh W, et al. Perspectives on the etiology of chronic rhinosinusitis: An immune barrier hypothesis. Am J Rhinol 22:549-559, 2008.
23. Jiang X-D, Li G-Y, Li L, et al. The characterization of IL-17A expression in patients with chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy 25:e171-e175, 2011.
24. Hvid M, Vestergaard C, Kemp K, et al. IL-25 in atopic dermatitis: A possible link between inflammation and skin barrier dysfunction. J Invest Dermatol 131:150-157, 2010.
25. Corrigan CJ, Wang W, Meng Q, et al. Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses. J Allergy Clin Immunol 128:116-124, 2011.
26. Lüthi AU, Cullen SP, McNeela EA, et al. Suppression of interleukin- 33 bioactivity through proteolysis by apoptotic caspases. Immunity 31:84-98, 2009.
27. Reh DD, Wang Y, Ramanathan M Jr, and Lane AP. Treatmentrecalcitrant chronic rhinosinusitis with polyps is associated with altered epithelial cell expression of interleukin-33. Am J Rhinol Allergy 24:105-109, 2011.
28. Kimura S, Pawankar R, Mori S, et al. Increased expression and role of thymic stromal lymphopoietin in nasal polyposis. Allergy Asthma Immunol Res 3:186-193, 2011.
29. Boita M, Garzaro M, Raimondo L, et al. The expression of TSLP receptor in chronic rhinosinusitis with and without nasal polyps. Int J Immunopathol Pharmacol 24:761, 2011.
30. Moro K, Yamada T, Tanabe M, et al. Innate production of TH2 cytokines by adipose tissue-associated c-Kit+ Sca-1+ lymphoid cells. Nature 463:540-544, 2009.
31. Price AE, Liang HE, Sullivan BM, et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci U S A 107:11489, 2010.
32. Mjosberg JM, Trifari S, Crellin NK, et al. Human IL-25- and IL-33- responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 12:1055-62, 2011.
33. Coffman RL. Immunology. The origin of TH2 responses. Science 328:1116-1117, 2010.